CA964193A - Injectable compositions containing salts of l-tetramisole - Google Patents

Injectable compositions containing salts of l-tetramisole

Info

Publication number
CA964193A
CA964193A CA088,685A CA88685A CA964193A CA 964193 A CA964193 A CA 964193A CA 88685 A CA88685 A CA 88685A CA 964193 A CA964193 A CA 964193A
Authority
CA
Canada
Prior art keywords
tetramisole
compositions containing
injectable compositions
containing salts
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA088,685A
Other languages
English (en)
Other versions
CA88685S (en
Inventor
Bruce A. Forsyth
David E. Pryor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orica Ltd
Original Assignee
Imperial Chemical Industries of Australia and New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries of Australia and New Zealand Ltd filed Critical Imperial Chemical Industries of Australia and New Zealand Ltd
Application granted granted Critical
Publication of CA964193A publication Critical patent/CA964193A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA088,685A 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole Expired CA964193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU5831169 1969-07-21

Publications (1)

Publication Number Publication Date
CA964193A true CA964193A (en) 1975-03-11

Family

ID=3743604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA088,685A Expired CA964193A (en) 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole

Country Status (9)

Country Link
US (1) US3670086A (enExample)
BE (1) BE753710A (enExample)
CA (1) CA964193A (enExample)
DE (1) DE2036114C3 (enExample)
FR (1) FR2059541B1 (enExample)
GB (1) GB1287673A (enExample)
IE (1) IE34373B1 (enExample)
NL (1) NL165653C (enExample)
ZA (1) ZA704419B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
WO2005018551A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
CA2536136C (en) 2003-08-27 2012-10-30 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
MY161812A (en) 2003-11-25 2017-05-15 3M Innovative Properties Co Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
TW200612932A (en) 2004-03-24 2006-05-01 3M Innovative Properties Co Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US20070259881A1 (en) * 2004-06-18 2007-11-08 Dellaria Joseph F Jr Substituted Imidazo Ring Systems and Methods
EP1835915A4 (en) * 2004-12-30 2010-02-24 Coley Pharm Group Inc FORMULATIONS AND METHOD FOR MODIFYING THE IMMUNE RESPONSE
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
EP1863814A1 (en) 2005-04-01 2007-12-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
CN104906036A (zh) * 2015-06-12 2015-09-16 重庆市畜牧科学院 阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (enExample) * 1964-05-11
AU421744B2 (en) * 1967-08-24 1972-02-24 I. C. I. Australia Limited Chemical process

Also Published As

Publication number Publication date
NL165653B (nl) 1980-12-15
IE34373B1 (en) 1975-04-16
GB1287673A (en) 1972-09-06
DE2036114A1 (de) 1971-02-04
NL7010558A (enExample) 1971-01-25
US3670086A (en) 1972-06-13
FR2059541A1 (enExample) 1971-06-04
DE2036114C3 (de) 1979-09-13
BE753710A (fr) 1970-12-31
IE34373L (en) 1971-01-21
DE2036114B2 (de) 1979-01-18
NL165653C (nl) 1981-05-15
ZA704419B (en) 1971-04-28
FR2059541B1 (enExample) 1974-10-11

Similar Documents

Publication Publication Date Title
CA964193A (en) Injectable compositions containing salts of l-tetramisole
CA955390A (en) Compositions containing aminopolyureylene resin
ZM4370A1 (en) Novel compositions of matter
CA978538A (en) Phosphonate compositions
GB1324599A (en) Manufacture of rubber-bitumen compositions
CA927079A (en) Pressure-oxidation of metal-sulfur-containing compositions
IL34089A (en) Pharmaceutical compositions containing penicillin or cephalosphorin derivatives
CA923425A (en) Compositions containing garcinia acid
CA979900A (en) Dialkyltin salts of substituted pyridine-1-oxides
AU450313B2 (en) Injectable oxytetracycline compositions
AU4960269A (en) Composition of matter
AU4067468A (en) Compositions of matter
AU453663B2 (en) Compositions containing n-dioctylethylene-triamines
AU437962B2 (en) Compositions of matter
CA777802A (en) Compositions of matter
AU456939B2 (en) Ester containing composition
AU1292270A (en) Improved beverage-forming compositions
AU453959B2 (en) Hydroxycitric acid derivatives containing compositions
AU449360B2 (en) Stabilizing composition
CA836563A (en) Composition of matter
CA796212A (en) Stabilized composition of quinonedihalimide compound
CA822730A (en) Compositions containing graphite
CA830476A (en) Therapeutic compositions containing aminocyclobutanols
AU1240870A (en) Injectable oxytetracycline compositions
ZM8570A1 (en) Composition of matter